Skip to Main Content
Table 1—

Baseline characteristics

PlaceboAtorvastatin
10 mg80 mg
n 65 67 66 
Male sex (%) 48 62 54 
Age (years) 58.5 ± 7.3 59.4 ± 7.6 60.5 ± 7.8 
Diabetes duration (years) 9.5 ± 6.1 12.2 ± 7.7 13.2 ± 8.5* 
Diabetes treatment (%)    
 Diet 3.1 1.5 
 Tablets 40.6 50.0 43.9 
 Insulin 31.3 27.3 27.3 
 Combination 25.0 21.2 28.8 
BMI (kg/m231.9 ± 6.1 30.1 ± 3.8 30.6 ± 4.5 
WHR 0.99 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 
Hypertension (%) 48 49 62 
Current smoking (%) 58 66 70 
Fasting glucose (mmol/l) 10.5 ± 3.6 10.4 ± 3.0 10.6 ± 3.0 
HbA1c (%) 8.3 ± 1.2 8.3 ± 1.2 8.4 ± 1.1 
Total cholesterol (mmol/l) 6.1 ± 0.9 5.9 ± 0.8 6.0 ± 1.0 
LDL cholesterol (mmol/l) 3.7 ± 0.9 3.6 ± 0.8 3.7 ± 0.9 
HDL cholesterol (mmol/l) 1.05 ± 0.2 1.06 ± 0.3 1.04 ± 0.2 
Triglycerides (mmol/l) 2.64 ± 0.9 2.50 ± 0.9 2.82 ± 1.1 
PlaceboAtorvastatin
10 mg80 mg
n 65 67 66 
Male sex (%) 48 62 54 
Age (years) 58.5 ± 7.3 59.4 ± 7.6 60.5 ± 7.8 
Diabetes duration (years) 9.5 ± 6.1 12.2 ± 7.7 13.2 ± 8.5* 
Diabetes treatment (%)    
 Diet 3.1 1.5 
 Tablets 40.6 50.0 43.9 
 Insulin 31.3 27.3 27.3 
 Combination 25.0 21.2 28.8 
BMI (kg/m231.9 ± 6.1 30.1 ± 3.8 30.6 ± 4.5 
WHR 0.99 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 
Hypertension (%) 48 49 62 
Current smoking (%) 58 66 70 
Fasting glucose (mmol/l) 10.5 ± 3.6 10.4 ± 3.0 10.6 ± 3.0 
HbA1c (%) 8.3 ± 1.2 8.3 ± 1.2 8.4 ± 1.1 
Total cholesterol (mmol/l) 6.1 ± 0.9 5.9 ± 0.8 6.0 ± 1.0 
LDL cholesterol (mmol/l) 3.7 ± 0.9 3.6 ± 0.8 3.7 ± 0.9 
HDL cholesterol (mmol/l) 1.05 ± 0.2 1.06 ± 0.3 1.04 ± 0.2 
Triglycerides (mmol/l) 2.64 ± 0.9 2.50 ± 0.9 2.82 ± 1.1 

Continuous data are means ± SD.

*

P < 0.05 between atorvastatin 80 mg and placebo group.

Close Modal

or Create an Account

Close Modal
Close Modal